subscribe: Posts | Comments

Avastin not approved for breast cancer patients

0 comments

Summary of story from BBC News, cost 24.2.11

The drug Avastin, also known as bevacizumab, should not be used to treat breast cancer patients, according to NICE, the drugs advisory organisation for England and Wales.

Trials had suggested that, used alongside chemotherapy drug paclitaxel, Avastin could help slow the growth and spread of tumours by five months more than paclitaxel alone.

But the National Institute for Health and Clinical Excellence (NICE), says there is not sufficient evidence that the drug will prolong or improve patients’ quality of life.

Sir Andrew Dillon, chief executive of NICE, said the evidence in favour of using Avastin was “not robust and overall did not show enough of a demonstrable benefit for it to be considered a cost-effective use of NHS resources.”

Doctors who believe patients could benefit from Avastin can apply for funding through the Cancer Drugs Fund, an option supported by cancer charities Breast Cancer Care and Breakthrough Breast Cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *